7.22.20 | Maternal Health SWHR Endorses Mothers and Newborns Success Act
Society for Women’s Health Research President and CEO Kathryn G. Schubert, MPP, issued the following statement: “The Society for Women’s […]
7.20.20 | Health Equity SWHR Calls on HHS to Address Structural Racism with Action on Section 1115 Demonstrations
SWHR joined 279 other organizations calling on Department of Health and Human Services (HHS) Secretary Alex Azar to address racial […]
7.14.20 | Policy SWHR Applauds House Appropriations Committee for Advancing HHS Funding Increases
In the midst of the COVID-19 pandemic, the work of U.S. public health agencies is more important than ever. SWHR commends the House Appropriations Committee on its approval of a FY21 appropriations bill increasing funding for NIH to $47 billion.
7.10.20 | Coronavirus SWHR Urges Renewal of Public Health Emergency Declaration for COVID-19
SWHR signed on to a recent letter urging the Department of Health and Human Services (HHS) to renew the public […]
7.2.20 | Maternal Health SWHR Applauds Work of PRGLAC Task Force
SWHR provided comments to the Eunice Kennedy Shriver National Institute of Child Health and Human Development following the June 24 public […]
6.30.20 | Policy Women and Value Assessment: Striving to Capture the Patient Experience
SWHR hosted three value assessment experts at its recent policy meeting to discuss the integration of women’s health priorities into assessments of new health care innovations.
6.25.20 | Uterine Fibroids SWHR Supports Uterine Fibroid Research and Education Act
SWHR signed onto a congressional letter of support for H.R. 6383, the Uterine Fibroid Research and Education Act of 2020. […]
6.23.20 | Coronavirus SWHR Feedback to Senate HELP Committee Chair on Pandemic Preparedness Plan
SWHR provided feedback on a white paper from Sen. Lamar Alexander, chair of the Senate Health, Education, Labor, and Pensions […]
6.19.20 | Coronavirus SWHR Urges Inclusion of At-Risk Women in COVID-19 Research
SWHR joined 25 organizations in urging the Food and Drug Administration (FDA) and National Institutes of Health (NIH) to include […]
6.17.20 | Policy SWHR Comments to CDC on Management of Acute and Chronic Pain
SWHR provided the Centers for Disease Control and Prevention (CDC) with requested comments on Management of Acute and Chronic Pain. […]
